Cixutumumab Biosimilar (IGF1R / CD221 Reference Antibody)
Cixutumumab (IMC-A12) is a human anti-IGF-1R monoclonal antibody with high affinity that inhibits ligand-dependent receptor activation and downstream signaling. Cixutumumab also mediates the internalization and degradation of IGF-IR. Cixutumumab shows broad-spectrum anti-tumour activity and can be used in studies of cancers such as lung cancer, malignancies, leukaemia, non-small cell lung cancer and prostate cancer.
Product Specifications
Target
Cixutumumab Biosimilar (Anti-IGF1R / CD221 Reference Antibody)
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Immunology & Inflammation
Purity
>98%
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC234685A1V 250 µL
Human DIP13B (APPL2) (NM_001251904) AAV Particle
Sign In for Pricing
View Details 
MBS6497518-01 0.1 mL
Rheb (Ras Homolog Enriched in Brain, GTP-binding Protein Rheb, MGC111559, Ras Homolog Enriched in Brain 2, RHEB2) (MaxLight 750)
Sign In for Pricing
View Details MBS6497518-02 5x 0.1 mL
Rheb (Ras Homolog Enriched in Brain, GTP-binding Protein Rheb, MGC111559, Ras Homolog Enriched in Brain 2, RHEB2) (MaxLight 750)
Sign In for Pricing
View Details